| Diabetes, n = 276 | No diabetes, n = 1150 | Total n (%) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
n (column%) unless otherwise stated | n (column%) unless otherwise stated | |||||||||
Albuminuria status | None (n = 195) | Micro albuminuria (n = 63) | Macro albuminuria (n = 18) | Subtotal diabetes | None (n = 981) | Micro albuminuria (n = 149) | Macro albuminuria (n = 20) | Subtotal no diabetes | n = 1426 | |
Mean BP (SD) | Systolic | 132 (17) | 140 (20) | 155 (22) | 135 (19) | 133 (18) | 136 (19) | 141 (18) | 135 (18) | 134 (18) |
 | Diastolic | 68 (10) | 69 (10) | 72 (11) | 68 (10) | 73 (11) | 75 (11) | 76 (9) | 73 (11) | 72 (11) |
BP controlled (NICE target)* | Yes | 84 (43.1) | 19 (30.2) | 3 (16.7) | 106 (38.4) | 631 (64.3) | 86 (57.7) | 6 (30.0) | 723 (62.9) | 829 (58.1) |
 | No | 111 (56.9) | 44 (69.8) | 15 (83.3) | 170 (61.8) | 350 (35.7) | 63 (42.3) | 14 (70.0) | 425 (37.0) | 597 (41.9) |
BP controlled (KDOQI target)** | Yes | 84 (43.1) | 19 (30.2) | 3 (16.7) | 106 (38.4) | 355 (36.2) | 48 (32.2) | 4 (20.0) | 407 (35.3) | 512 (35.9) |
 | No | 111 (56.9) | 44 (69.8) | 15 (83.3) | 170 (61.8) | 626 (63.8) | 101 (67.8) | 16 (80.0) | 115 (68.9) | 914 (64.1) |
BP controlled (KDIGO target)*** | Yes | 141 (72.3) | 21 (33.3) | 3 (16.7) | 165 (59.8) | 639 (65.1) | 52 (34.9) | 4 (22.2) | 695 (60.4) | 859 (60.2) |
 | No | 54 (27.7) | 42 (40.4) | 15 (83.3) | 111 (40.2) | 342 (34.9) | 97 (65.1) | 14 (77.8) | 453 (39.4) | 576 (39.8) |
Number of anti-hypertensive agents | 1 | 79 (40.5) | 25 (39.7) | 3 (16.7) | 107 (38.9) | 433 (44.1) | 65 (43.6) | 8 (40.0) | 506 (44.1) | 615 (43.1) |
 | 2 | 54 (27.7) | 19 (30.2) | 5 (27.8) | 78 (28.3) | 345 (35.2) | 61 (40.9) | 4 (20.0) | 410 (35.7) | 488 (34.2) |
 | 3 or more | 62 (31.8) | 19 (30.2) | 10 (55.6) | 90 (32.6) | 203 (20.7) | 23 (15.4) | 8 (40.0) | 232 (20.2) | 323 (22.7) |
Taking RAASi | Yes | 173 (88.7) | 56 (88.9) | 15 (83.3) | 243 (88.4) | 750 (76.5) | 112 (75.2) | 17 (85.0) | 877 (76.4) | 1123 (78.8) |
 | No | 22 (11.3) | 7 (11.1) | 3 (16.7) | 32 (11.6) | 231 (23.5) | 37 (24.8) | 3 (15.0) | 271 (23.6) | 303 (21.2) |